Company / Current Liabilities per Share
Ventyx Biosciences, Inc. Current Liabilities per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.19
FY2024
5-year range
$0.19 / $0.96
FY2020-FY2024
Trend
-50.9%
vs FY2023
Sector context
#193 of 208
Health Care
What the data says
Among 208 Health Care companies, Ventyx Biosciences, Inc. is in the top 7% for current liabilities per share. Current Liabilities per Share has fluctuated over the past 5 years, ranging from $0.19 in FY2024 to $0.96 in FY2021.
Based on SEC 10-K filings.
0.19 in FY2024 with a 3-year CAGR of -42.0%.
Improved from $0.31 to $0.19 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -42.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 208This company $0.19 Sector average $26.71
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 50.9% year-over-year.
- Ranks #193 out of 208 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.19 | -50.9% |
| FY2023 | $0.38 | +22.0% |
| FY2022 | $0.31 | -67.4% |
| FY2021 | $0.96 | +35.7% |
| FY2020 | $0.71 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026